Regenicin, Inc.: 10-Q filed 2021-08-23
What Regenicin, Inc. reported in its quarterly report filed 2021-08-23 (fiscal Q3 2021): 19 published measures, 63 facts as tagged in accession 0001662252-21-000018.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2021-08-23
- Fiscal period
- fiscal Q3 2021
- Accession
- 0001662252-21-000018 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Regenicin, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 4,680 | USD | |
| At 2020-09-30 | 4,141 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | -4,845,803 | USD | |
| At 2021-03-31 | -4,680,458 | USD | |
| At 2020-12-31 | -4,447,154 | USD | |
| At 2020-09-30 | -4,287,276 | USD | |
| At 2020-06-30 | -4,286,157 | USD | |
| At 2020-03-31 | -4,114,319 | USD | |
| At 2019-12-31 | -3,925,671 | USD | |
| At 2019-09-30 | -3,727,685 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | -165,345 | USD | 91 |
| 2020-10-01 to 2021-06-30 | -558,527 | USD | 273 |
| 2021-01-01 to 2021-03-31 | -233,304 | USD | 90 |
| 2020-10-01 to 2020-12-31 | -159,878 | USD | 92 |
| 2020-04-01 to 2020-06-30 | -171,838 | USD | 91 |
| 2019-10-01 to 2020-06-30 | -558,472 | USD | 274 |
| 2020-01-01 to 2020-03-31 | -188,648 | USD | 91 |
| 2019-10-01 to 2019-12-31 | -197,986 | USD | 92 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-10-01 to 2021-06-30 | -22,161 | USD | 273 |
| 2019-10-01 to 2020-06-30 | -96,961 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-10-01 to 2021-06-30 | 23,600 | USD | 273 |
| 2019-10-01 to 2020-06-30 | 97,550 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 15,208,513 | USD | |
| At 2020-09-30 | 14,649,986 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 153,483,050 | shares | 91 |
| 2020-10-01 to 2021-06-30 | 153,483,050 | shares | 273 |
| 2020-04-01 to 2020-06-30 | 153,483,050 | shares | 91 |
| 2019-10-01 to 2020-06-30 | 153,483,050 | shares | 274 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 153,483,050 | shares | 91 |
| 2020-10-01 to 2021-06-30 | 153,483,050 | shares | 273 |
| 2020-04-01 to 2020-06-30 | 153,483,050 | shares | 91 |
| 2019-10-01 to 2020-06-30 | 153,483,050 | shares | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | -155,559 | USD | 91 |
| 2020-10-01 to 2021-06-30 | -532,113 | USD | 273 |
| 2020-04-01 to 2020-06-30 | -162,054 | USD | 91 |
| 2019-10-01 to 2020-06-30 | -517,262 | USD | 274 |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 8,811 | USD | 91 |
| 2020-10-01 to 2021-06-30 | 25,514 | USD | 273 |
| 2020-04-01 to 2020-06-30 | 8,559 | USD | 91 |
| 2019-10-01 to 2020-06-30 | 38,410 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 4,850,483 | USD | |
| At 2020-09-30 | 4,291,417 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 93,675 | USD | |
| At 2020-09-30 | 88,659 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 155,559 | USD | 91 |
| 2020-10-01 to 2021-06-30 | 532,113 | USD | 273 |
| 2020-04-01 to 2020-06-30 | 162,054 | USD | 91 |
| 2019-10-01 to 2020-06-30 | 517,262 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 153,483,050 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 10,208,339 | USD | |
| At 2020-09-30 | 10,208,339 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | -4,845,803 | USD | |
| At 2020-09-30 | -4,287,276 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 269,139 | USD | |
| At 2020-09-30 | 174,438 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | -182,996 | USD | 91 |
| 2020-10-01 to 2021-06-30 | -611,481 | USD | 273 |
| 2020-04-01 to 2020-06-30 | -189,489 | USD | 91 |
| 2019-10-01 to 2020-06-30 | -611,619 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 155,559 | USD | 91 |
| 2020-10-01 to 2021-06-30 | 532,113 | USD | 273 |
| 2020-04-01 to 2020-06-30 | 162,054 | USD | 91 |
| 2019-10-01 to 2020-06-30 | 517,262 | USD | 274 |
Inspect the source
- Entity
- Regenicin, Inc. / CIK 0001412659
- Captured
- SEC response SHA-256
66d33e554adc1e643294d5e778c52aa5121a74d07c71bf640453c952267c0d14
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001412659.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))